Press release
Natamycin Market is Expected to Achieve USD 109 Million at CAGR of 3.7% by 2035
Natamycin Market
Natamycin's fungistatic properties, coupled with its versatility in formulation, make it a preferred choice in the expanding dairy and meat processing sectors-especially in Asia and North America. Its ability to extend product shelf life while maintaining compliance with regulatory standards allows manufacturers to streamline preservation strategies using a single, multifunctional ingredient.
For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=1378
Key Drivers of Market Growth
1. Clean‐Label and Natural Trend: Consumers now expect natural, recognizable ingredients. Natamycin fits this trend as a naturally sourced preservative, prompting food processors to replace synthetic options.
2. Strong Regulatory Support: Approved by authorities like the FDA, EFSA, and various countries worldwide, natamycin is recognized as safe and effective-boosting confidence among manufacturers.
3. Rising Dairy & Meat Processing: As dairy consumption grows worldwide, especially in North America and Asia, natamycin sees increased use in cheese, yogurt, and processed meats to prevent spoilage and extend shelf life.
4. Versatile Product Formulation: Effective at low concentrations and with minimal sensory impact, natamycin accommodates various applications-allowing manufacturers to streamline formulations.
5. Pharmaceutical Utilization: Natamycin is an essential antifungal for treating ocular infections like fungal keratitis and conjunctivitis, increasing demand in the pharma sector.
6. Emerging Applications: Innovations such as controlled-release coatings in agriculture and animal feed are broadening natamycin's utility in crop preservation and livestock nutrition
What Are the Primary Regulatory and Formulation Challenges Restricting Growth in the Natamycin Market Today?
Despite its advantages, the natamycin market faces several growth restraints. A key challenge lies in the regulatory disparities across regions-natamycin's approval for use in food products is not uniform worldwide. In some areas, regulatory clearance is limited or entirely absent, hindering broader adoption.
Formulation challenges also play a significant role. High manufacturing costs and limited availability of raw materials can constrain large-scale production. Additionally, persistent consumer misconceptions around preservatives-natural or synthetic-can limit market acceptance of natamycin.
Competition from other antifungal agents and synthetic preservatives, often available at lower prices, poses another threat. These alternatives can more easily penetrate fresh produce and packaged food segments, challenging natamycin's market position. To maintain a competitive edge, continuous innovation, public education, and regulatory harmonization are essential.
Which Regions Are Driving Natamycin Market Growth Through Increased Food Preservation Demand?
North America, particularly the U.S., is leading growth due to strong demand in food processing and pharmaceuticals, backed by regulatory support for natural preservatives and rising consumer preference for clean-label products.
East Asia, especially China, is witnessing rapid growth driven by expanding food production, rising consumption of packaged foods, and growing awareness of food safety. The region also benefits from cost-effective manufacturing.
Western Europe remains a key market, supported by strict food safety regulations and high demand for natural preservatives in dairy and bakery sectors, especially in countries like Germany and the Netherlands.
Competitive Analysis
The Natamycin market is shaped by a mix of global leaders and regional manufacturers. DSM leads with its Delvo®Cid+ solution for natural preservation in dairy and bakery products. Handary offers a range of natamycin-based products like Natap and Natadex. Other notable players include Silver-Elephant, Sinofi Ingredients, Octagon Chemicals, Beijing Oriental Rada, Jiaozuo Joincare, Lanzhou Weiri, Langfang Meihua, and Pucheng Lifecome-each contributing through high-quality production, innovation, and compliance with international standards.
Recent Developments:
September 2024: Tocopharm Co., Ltd. launched a high-purity Natamycin API (99.5%) for pharmaceutical use, aimed at advanced antifungal treatments.
July 2024: Handary introduced Natamax® Antifungal Films-biodegradable packaging with natamycin-to extend the shelf life of bakery products while supporting sustainability.
Browse Full Report: https://www.factmr.com/report/1378/natamycin-market
Segmentation of Natamycin Market Research
By Type :
Glucose-Based Natamycin
Lactose-Based Natamycin
Sodium Chloride-Based Natamycin
Other Formulations
By Form :
Powder
Liquid Suspension
Granules
By Application :
Food Preservation
Pharmaceutical
Animal Feed
Agriculture
By End User Industry :
Food & Beverage
Pharmaceuticals
Agrochemicals
Feed Industry
By Region :
North America
Latin America
Western Europe
Eastern Europe
East Asia
South Asia & Pacific
Middle East & Africa
Check out More Related Studies Published by Fact.MR:
Birch Water Market
https://www.factmr.com/report/4060/birch-water-market
Breast Milk Substitute Market
https://www.factmr.com/report/breast-milk-substitute-market
Pastry Fillings Market
https://www.factmr.com/report/4778/pastry-fillings-market
Clover Leaf Oil Market
https://www.factmr.com/report/90/clover-leaf-oil-market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Natamycin Market is Expected to Achieve USD 109 Million at CAGR of 3.7% by 2035 here
News-ID: 4095339 • Views: …
More Releases from Fact.MR
Blockchain in Telecom Market to Surge from USD 795.8 Million in 2025 to USD 211, …
The global blockchain in telecom market is making significant strides as telecom operators, infrastructure providers, and technology vendors increasingly turn to decentralized ledger technologies to address challenges such as fraud, identity verification, and transparency. According to the latest Fact.MR analysis, the market is valued at USD 795.8 million in 2025, illustrating how blockchain is no longer a fringe concept but a growing core component in telecom strategies.
Telecom companies are…
Translation Software Market Growing at around 6.5% CAGR (2025-2035)
The translation software market has reached an estimated value of USD 10.7 billion in 2025, as globalization intensifies and digital content proliferates across industries. Businesses are increasingly publishing content in multiple languages to capture international markets, comply with regulations, and improve customer experience. Advances in artificial intelligence, especially neural machine translation models, are enhancing accuracy and reducing time lag, making software translation a more viable alternative to human translation for…
Sterility Indicators Market Valued at USD 1.37 Billion in 2025 | Fact.MR Analysi …
The global sterility indicators market has firmly established its importance by 2025, reaching an estimated valuation of USD 1.37 billion. This growth reflects increasing global emphasis on infection prevention, sterilization validation, and quality compliance in healthcare, pharmaceutical, and medical device manufacturing sectors. Hospitals, clinics, and labs are demanding both biological and chemical indicators to ensure that sterilization processes-whether via steam, heat, radiation, or chemical agents-meet the required safety and regulatory…
Antibody Fragments Market is Growing at a CAGR of 6.2% by 2035 | Key Players: No …
The global antibody fragments market has firmly established its importance in biopharmaceuticals and diagnostics by 2024, achieving a valuation of approximately USD 8,563 million. Growth to this level has been driven by increasing incidence of chronic and immunological disorders, rising demand for more precise and targeted therapies, and improvements in biologic technologies.
Antibody fragments, which include Fab, scFv, sdAb and other smaller binding modules, are finding favor due to their…
More Releases for Natamycin
Natamycin Market Expecting Huge Demand in Upcoming Years
The "Natamycin Market" intelligence report, just published by USD Analytics Market, covers a micro-level study of important market niches, product offers, and sales channels. to determine market size, potential, growth trends, and competitive environment, the Natamycin Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the study featured Danisco (Denmark),…
Global Natamycin Market Research Report 2023-2029
Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.
Natamycin report published by QYResearch reveals that…
Natamycin Market Expected to Deliver Dynamic Progression until 2028(On the basis …
Natamycin Market Outlook:
Natamycin is commonly known as Natacyn. Natamycin is used mostly as a natural preservative in the food and beverage industry. Natamycin is globally permitted preservative which helps to protect a wide range of products such as fermented meat, beverage, cheese, wines, baked goods and yogurt against yeasts and molds. Natamycin is given a preference among other preservatives because of its efficient and natural food preservation method and its…
Natamycin Market: Opportunities, Demand and Forecasts, 2018–2028
Natamycin Market Outlook:
Natamycin is commonly known as Natacyn. Natamycin is used mostly as a natural preservative in the food and beverage industry. Natamycin is globally permitted preservative which helps to protect a wide range of products such as fermented meat, beverage, cheese, wines, baked goods and yogurt against yeasts and molds. Natamycin is given a preference among other preservatives because of its efficient and natural food preservation method and its…
Global Natamycin Market to Witness a Pronounce Growth During 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Natamycin market.
Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also…
Natamycin Market Greater Revenue Share by 2018 to 2028
Natamycin Market Outlook:
Natamycin is commonly known as Natacyn. Natamycin is used mostly as a natural preservative in the food and beverage industry. Natamycin is globally permitted preservative which helps to protect a wide range of products such as fermented meat, beverage, cheese, wines, baked goods and yogurt against yeasts and molds. Natamycin is given a preference among other preservatives because of its efficient and natural food preservation method and its…
